News Archives - Biologics by McKesson

REZUROCK™ (belumosudil) Tablets, FDA Approved for Treatment of Chronic Graft-Versus-Host Disease, Available at Biologics by McKesson

Jul 30, 2021 | News, Press Release

CARY, N.C., JULY 30, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, today announced that it has been selected by Kadmon (Nasdaq: KDMN) as a specialty pharmacy provider for REZUROCK™ (belumosudil) for the...

A Letter to Our Biopharma Clients About Organizational Changes

Nov 6, 2020 | News

Valued Biopharma Partner, At Biologics by McKesson, we know that your complex, personalized therapies require customized support tailored to your unique needs. It is a privilege to serve as a partner to you in your product commercialization, collaborating to maximize...

A Letter to Our Customers from Our New General Manager, Brandon Tom

Jul 2, 2020 | News

Valued Customers, As the new vice president and general manager of Biologics by McKesson, let me start by saying I am truly thrilled to lead this wonderful company and the amazing people who provide our services to you and your patients every day. I am also equally...

Our Response to COVID-19 from the President of McKesson Life Sciences

Mar 12, 2020 | News

Dear Customer, COVID-19 (coronavirus) is top of mind for us at McKesson Life Sciences and it is a situation that we are closely monitoring. We understand the responsibility we have to providers, stakeholders and patients. We also take the health and welfare of our...